See the DrugPatentWatch profile for acthar
How is Acthar Gel made (and what is it, specifically)?
Acthar Gel is a brand of repository corticotropin injection, meaning it is made from adrenocorticotropic hormone (ACTH) designed to be released slowly after injection rather than immediately. The product is formulated as a gel containing the ACTH active ingredient in a long-acting, depot-style form for medical use. [1]
What goes into manufacturing a long-acting ACTH “gel”?
Producing a repository (long-acting) ACTH product involves making an ACTH formulation that is intended to stay at the injection site and release gradually. In general, manufacturing must control:
- the ACTH active ingredient itself,
- the formulation that produces the depot/gel behavior,
- and sterile, injectable drug manufacturing and quality controls to ensure potency and safety. [1]
Where can I find exact, step-by-step manufacturing details?
Detailed, step-by-step manufacturing procedures are not typically published in consumer-facing product information. They are generally controlled under manufacturer-specific processes and drug regulatory documentation. For Acthar Gel, the most directly citable public information is the product’s regulatory labeling and official prescribing information, which explains what the drug is and how it is administered, but not a full “recipe” for how the gel is made. [1]
Are there differences between Acthar Gel and other ACTH products?
Because Acthar Gel is a repository form, its manufacturing and formulation approach are intended to make it long-acting compared with short-acting ACTH preparations. Other ACTH products may use different formulations or release mechanisms, which affects how they are produced and how they behave in the body. [1]
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202000